https://finviz.com/news/310528/can-willdans-deal-pipeline-power-2026-eps-growth-ahead
Can Willdan's Deal Pipeline Power 2026 EPS Growth Ahead?
Stock screener for investors and traders, financial visualizations.
deal pipelineeps growthpower2026ahead
https://www.marketscreener.com/quote/stock/AUTOMATIC-DATA-PROCESSING-11713/news/ADP-4Q-Net-Up-Sees-Fiscal-Year-EPS-Growth-47516105/
ADP 4Q Net Up, Sees Fiscal Year EPS Growth | MarketScreener
Jul 31, 2024 - By Rob Curran Payroll-services company Automatic Data Processing on Wednesday registered brisk fiscal fourth-quarter earnings growth and forecast more gains in...
fiscal yeareps growthadp4qsees
https://simplywall.st/stocks/de/diversified-financials/etr-mlp/mlp-shares/news/if-eps-growth-is-important-to-you-mlp-etrmlp-presents-an-opp
If EPS Growth Is Important To You, MLP (ETR:MLP) Presents An Opportunity - Simply Wall St News
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
https://www.nasdaq.com/market-activity/stocks/igta/revenue-eps
Inception Growth Acquisition Limited (IGTA) Revenue EPS | Nasdaq
Find the latest Revenue Earnings Per Share data for Inception Growth Acquisition Limited (IGTA) at Nasdaq.com.
inceptiongrowthacquisitionlimitedigta
https://marketrealist.com/2019/02/abbvie-or-celgene-which-is-expected-to-report-faster-eps-growth/
AbbVie or Celgene: Which Is Expected to Report Faster EPS Growth?
Feb 8, 2019 - On its fourth-quarter earnings conference call, AbbVie (ABBV) guided for an adjusted gross margin of 82.5% in 2019.
is expected toabbviecelgene
https://simplywall.st/stocks/sg/capital-goods/sgx-f13/fu-yu-shares/news/with-eps-growth-and-more-fu-yu-sgxf13-is-interesting
With EPS Growth And More, Fu Yu (SGX:F13) Is Interesting - Simply Wall St News
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
https://www.sanofi.com/en/media-room/press-releases/2022/2022-04-28-05-30-00-2430908
Press Release: Sanofi continues to deliver strong business EPS growth driven by higher sales and...
Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins in Q1 Paris, April 28, 2022 Q1 2022 sales growth of 8.6%...
https://www.cgi.com/en/cgi-reports-16-billion-new-contract-bookings-and-strong-eps-growth-Q1-2010
CGI Reports $1.6 Billion in New Contract Bookings and Strong EPS Growth in Q1-F2010 | CGI.com